Literature DB >> 16051975

Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?

Mads Hald Andersen, Julie Gehl, Sine Reker, Poul Geertsen, Jürgen C Becker, Per thor Stratem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16051975     DOI： 10.1200/JCO.2004.00.9837

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.

Authors:  Ales Sedlar; Tanja Dolinsek; Bostjan Markelc; Lara Prosen; Simona Kranjc; Masa Bosnjak; Tanja Blagus; Maja Cemazar; Gregor Sersa
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

2.  Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients.

Authors:  Ruggero Ridolfi; Massimiliano Petrini; Laura Fiammenghi; Monica Stefanelli; Laura Ridolfi; Michela Ballardini; Giuseppe Migliori; Angela Riccobon
Journal:  J Transl Med       Date:  2006-08-16       Impact factor: 5.531

3.  Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases.

Authors:  Cynthia X L Chang; Anthony T Tan; Ming Yan Or; Kai Yee Toh; Pei Yiing Lim; Adeline S E Chia; Thomas M Froesig; Karen D Nadua; Hsueh-Ling J Oh; Hoe Nam Leong; Sine R Hadrup; Adam J Gehring; Yee-Joo Tan; Antonio Bertoletti; Gijsbert M Grotenbreg
Journal:  Eur J Immunol       Date:  2013-02-14       Impact factor: 5.532
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.